D-1502-2022 Class I Terminated

Recalled by Vi-Jon, LLC — Smyrna, TN

FDA drug recall D-1502-2022 was initiated by Vi-Jon, LLC on Jul 15, 2022 and is designated Class I. Reason for recall: Microbial contamination of non-sterile products. The recall status is terminated (terminated May 9, 2024). Affected quantity: 5,304 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 21, 2022
Initiation Date
Jul 15, 2022
Termination Date
May 9, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,304 bottles

Product description

EQUALINE magnesium citrate saline laxative, oral solution, (1.745 g/fl oz), DYE FREE lemon flavor, 10 FL OZ (296 mL), Distributed by Supervalu Inc. Eden Prairie, MN 55344 USA, or Distributed By UNFI Providence, RI 02908, NDC 41163-769-38 UPC 0 41163 50068 6

Reason for recall

Microbial contamination of non-sterile products.

Distribution pattern

Distributed Nationwide in the USA as well as Canada and Panama.

Code information

Lot # 0511629, EXP 12/4/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1502-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1502-2022. Report a data issue: hello@regdatalab.com.